Delivery Order SPE2DE24D0013-SPE2D625F96BU

Award Date 2/26/25
Potential Completion Date 3/12/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
The federal contract award, with ID SPE2DE24D0013|SPE2D625F48HV, was granted to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), under the Medical Supply Chain program. The $27,200.00 firm fixed-price delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $2,244.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The products are intended to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical conditions. The contract has a ceiling value of $2,720.00 and is a firm fixed-price delivery order...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract is a delivery order with a firm fixed price of $7,416.00 and an ultimate completion date of January 30, 2025. It was awarded by the Defense Logistics Agency, which is the Department of Defense's combat logistics support agency. The contract has no set-aside...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $2,040.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is not...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract, worth $2,720.00, is a firm fixed-price delivery order with a period of performance ending on March 7, 2025. Cepheid has been awarded this contract as a prime contractor, and the contract is not designated as a set-aside....
This federal contract award, SPE2DE24D0013|SPE2D625F96AX, was issued by the Defense Logistics Agency's Medical Supply Chain division to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The $13,096.80 firm fixed-price delivery order is for Cepheid to provide the government with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a ceiling value of $1,540.00, is a delivery order under the SPE2DE24D0013 and SPE2D625F80HV contract vehicles. The contract is for the provision of the Cepheid GeneXpert molecular diagnostic systems, reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19,...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F96BU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, identified as SPE2DE24D0013|SPE2D625F96BU, is a firm fixed-price delivery order with a ceiling value of $1,190.28 and an ultimate completion date of March 12, 2025.

Cepheid, the prime contractor, is providing the government with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to rapidly detect and diagnose a variety of infectious diseases, including COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The contract does not have a set-aside designation.

In addition to this contract award, Cepheid holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and the Indian Health Service, enabling these agencies to continuously procure Cepheid's molecular diagnostic products and services.

Generated 5/28/25, 10:50 AM